REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/18/2026
Back to search
Official data from USPTO
AI THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AI THERAPEUTICS
ST13
US500000088093745Class
42
Filing
88093745
Registration
6357944
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
05/19/2026
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
08/27/2018
Registration date
05/18/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2021
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
11/26/2018
First use in commerce
11/26/2018
Drawing code
4
Owner type
03
Owner location
GUILFORD, CT, US
Examiner
ERVIN, INGA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AI THERAPEUTICS, INC.
LAM Therapeutics, Inc.
Representatives
Susan N. Acquista, Esq. DLA Piper LLP (US)
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceuticalmedicalscientificbiopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticalsgeneticsgenome editinggene editinggenome engineeringgene modulationtranscriptional regulationtranscriptional modulationgenetic diseases
Publications
History of USPTO decisions and trademark events.
42 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/22/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/22/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/18/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/09/2021
ALIE
ASSIGNED TO LIE
04/09/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/09/2021
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/08/2021
IUAA
USE AMENDMENT ACCEPTED
04/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/26/2021
IUAF
USE AMENDMENT FILED
02/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/25/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/25/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/25/2020
GNFR
FINAL REFUSAL E-MAILED
08/25/2020
CNFR
FINAL REFUSAL WRITTEN
08/25/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/28/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/28/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/30/2020
GNRT
NON-FINAL ACTION E-MAILED
01/30/2020
CNRT
NON-FINAL ACTION WRITTEN
01/30/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/31/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/31/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/31/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2019
GNRT
NON-FINAL ACTION E-MAILED
07/02/2019
CNRT
NON-FINAL ACTION WRITTEN
07/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/18/2018
GNRT
NON-FINAL ACTION E-MAILED
12/18/2018
CNRT
NON-FINAL ACTION WRITTEN
12/18/2018
DOCK
ASSIGNED TO EXAMINER
12/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/05/2018
Continuous trademark protection
Get notified about every new filing that threatens AI THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.